Could less steroid be safer for vasculitis patients?
NCT ID NCT06983821
First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study tests whether a shorter, lower-dose steroid treatment (4 weeks) combined with standard medications works as well as the usual longer steroid course for people with ANCA vasculitis and severe kidney disease. About 36 adults with a new or returning flare of this condition will take part. The goal is to see if the shorter steroid plan reduces serious infections while still controlling the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St-Joseph's Hospital
NOT_YET_RECRUITINGHamilton, Ontario, Canada
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.